Antabio (private company)
See something wrong or missing? Let us know
Offices:Toulouse
Industry:BiotechHealth services
Business model:B2B
Antabio is a French developer of treatments for drug-resistant bacterial infections
Investors:
we tracked 6 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 27.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Antabio
Name | Criteria | |
---|---|---|
![]() |
Atai Life Sciences
63%
|
|
![]() |
Cinclus Pharma
63%
|
|
![]() |
Sano Genetics
63%
|
|
![]() |
Leyden Labs
63%
|
|
![]() |
Mogrify
63%
|
|
![]() |
Causaly
63%
|
|
![]() |
Ochre Bio
63%
|
|
![]() |
Xenothera
63%
|
|
![]() |
bit.bio
63%
|
|
![]() |
Synthace
63%
|
|